Pathways in small cell lung cancer and its therapeutic perspectives
Pingali M Shivapriya1, Anirudh Singh1, Priyanshu Pandey2
1Department of Applied Sciences, Indian Institute of Information Technology Allahabad, 211012 Allahabad, India.
Abstract:
Small cell lung cancer (SCLC) is known for its rapid growth with high metastatic spread. Its treatment remains a major challenge for oncologists due to the high mutation rate and other clinical disadvantages. The survival rate of these patients is very poor but there is no significant progress over the last few decades in the treatment protocols. Hence there is an urgency to design new clinical trials with novel drug combinations that can specifically and effectively target key pathways for proper treatment of SCLC. There have been several indications that developmental signalling pathways are involved in tumor growth, progression, metastasis and invasion of SCLC. Thus, it is anticipated that deciphering the signalling cascades of these embryonic signalling pathways may reveal novel therapeutic breakthroughs in SCLC. In this context, we have tried to assemble all the relevant information to give an updated overview of the various signalling pathways involved in the development of SCLC.
Insights
Small cell lung cancer (SCLC) is a challenging disease due to its rapid spread and poor outcomes. Understanding developmental signaling pathways offers new therapeutic targets for this aggressive cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Small cell lung cancer (SCLC) exhibits rapid growth and high metastatic potential.
- Current SCLC treatment protocols have seen limited progress, resulting in poor patient survival rates.
- High mutation rates and clinical disadvantages present significant challenges in SCLC management.
Purpose of the Study:
- To provide an updated overview of signaling pathways implicated in SCLC development.
- To highlight the role of developmental signaling pathways in SCLC tumor growth, progression, and metastasis.
- To identify potential novel therapeutic targets by deciphering these embryonic signaling cascades.
Main Methods:
- Literature review and information synthesis.
- Analysis of existing research on signaling pathways in SCLC.
- Compilation of data on developmental pathways involved in SCLC.
Main Results:
- Developmental signaling pathways are significantly involved in SCLC.
- These pathways regulate key aspects of SCLC, including tumor growth, metastasis, and invasion.
- Understanding these cascades is crucial for identifying new therapeutic strategies.
Conclusions:
- Deciphering embryonic signaling pathways in SCLC may lead to therapeutic breakthroughs.
- Novel drug combinations targeting these pathways are urgently needed for effective SCLC treatment.
- Further research into these pathways is essential for improving SCLC patient outcomes.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...